van der Helm-van Mil AH, Huizinga TW, de Vries RR, Toes RE (June 2007). "Emerging patterns of risk factor make-up enable subclassification of rheumatoid arthritis". Arthritis and Rheumatism. 56 (6): 1728–35.
doi:
10.1002/art.22716.
PMID17534941.
Cornec D, Cornec-Le Gall E, Fervenza FC, Specks U (October 2016). "ANCA-associated vasculitis - clinical utility of using ANCA specificity to classify patients". Nature Reviews. Rheumatology. 12 (10): 570–9.
doi:
10.1038/nrrheum.2016.123.
PMID27464484.
S2CID22205737.
Ohlsson K, Linder C, Rosengren M (July 1990). "Monoclonal antibodies specific for neutrophil proteinase 4. Production and use for isolation of the enzyme". Biological Chemistry Hoppe-Seyler. 371 (7): 549–55.
doi:
10.1515/bchm3.1990.371.2.549.
PMID2121162.
van der Helm-van Mil AH, Huizinga TW, de Vries RR, Toes RE (June 2007). "Emerging patterns of risk factor make-up enable subclassification of rheumatoid arthritis". Arthritis and Rheumatism. 56 (6): 1728–35.
doi:
10.1002/art.22716.
PMID17534941.
Cornec D, Cornec-Le Gall E, Fervenza FC, Specks U (October 2016). "ANCA-associated vasculitis - clinical utility of using ANCA specificity to classify patients". Nature Reviews. Rheumatology. 12 (10): 570–9.
doi:
10.1038/nrrheum.2016.123.
PMID27464484.
S2CID22205737.
Ohlsson K, Linder C, Rosengren M (July 1990). "Monoclonal antibodies specific for neutrophil proteinase 4. Production and use for isolation of the enzyme". Biological Chemistry Hoppe-Seyler. 371 (7): 549–55.
doi:
10.1515/bchm3.1990.371.2.549.
PMID2121162.